No recent analyst price targets found for INBP.
Latest News for INBP
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
HILLSIDE, NJ / ACCESS Newswire / February 11, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025. Revenue for the quarter ended December 31, 2025 was $11.3 million compared to $12.6 million for the quarter ended December 31, 2024, a decrease of $1.3 million or 10.3%.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INBP.
U.S. House Trading
No House trades found for INBP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.